Lesinurad (Zurampic)

Important notice: Lesinurad (Zurampic) as well as the combination drug Duzallo (lesinurad/allopurinol) is no longer available in the United States. The manufacturer stopped selling it in February 2019 for business reasons — not because of safety or effectiveness concerns. If you were taking lesinurad, please talk to your doctor about other options for managing your gout.
Lesinurad is used to lower high uric acid levels in the blood (a condition called hyperuricemia) in adults with gout who could not reach their uric acid target with a xanthine oxidase inhibitor (such as allopurinol or febuxostat) alone. In gout, high uric acid causes sharp crystals to form in the joints, leading to sudden, very painful flares. Lesinurad works by helping the kidneys remove more uric acid through the urine. It is always taken together with a xanthine oxidase inhibitor — never alone.
How To Take It
Lesinurad is taken as a 200 mg tablet once a day by mouth. It is always taken at the same time as a xanthine oxidase inhibitor such as allopurinol or febuxostat. Taking it without that other medicine greatly increased the risk of kidney failure. Eating a gout-friendly diet (reducing organ meats, shellfish, and alcohol) can also help lower uric acid levels.
Side Effects
The most serious risk of lesinurad is kidney damage or kidney failure. This risk is much higher when it is taken without a xanthine oxidase inhibitor.
Less serious side effects include headache, flu-like symptoms, and heartburn.
Lesinurad should not be used by patients with kidney failure, liver failure, those on dialysis, those with a kidney transplant, or those with Lesch-Nyhan syndrome or tumor lysis syndrome.
Tell Your Rheumatology Provider
Patients should inform their doctor about: signs of kidney problems (changes in urination, flank pain, or dehydration symptoms); regular aspirin use (which could make lesinurad less effective); and use of birth control pills (which lesinurad could make less effective).
The effects of lesinurad on an unborn baby are not fully known, and it is also unknown whether it passes into breast milk. Patients who are pregnant or planning to become pregnant should discuss this with their doctor before starting the medicine.
If you were previously prescribed lesinurad, and live in the U.S., please speak with your rheumatology provider about currently available alternatives for gout management.
Updated February 2026 by Diana Girnita, MD, PhD, and reviewed by the American College of Rheumatology Committee on Communications and Marketing.
This information is provided for general education only. Individuals should consult a qualified health care provider for professional medical advice, diagnosis and treatment of a medical or health condition.
Source: U.S. Food and Drug Administration. Zurampic (lesinurad) — FDA drug history and discontinuation, April 2019. drugs.com/history/zurampic.html
